The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes ...
In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...
Nebraska Medicine helps tens of thousands of patients every year, but one unique facility on campus can’t be found anywhere ...
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...
The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
Johnson & Johnson entered into a definitive agreement to acquire Halda Therapeutics OpCo for $3.05 billion in cash. Eli Lilly announced it will pay $40 million upfront and up to $2.56 billion in a ...
A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...
Introduction Age-related macular degeneration (AMD) is a prevalent eye disease among middle-aged and older adults. AMD leaves the patient with irreversible deteriorating vision, which profoundly ...
ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...
In this video, David A. Eichenbaum, MD, FASRS, discusses late-stage wet age-related macular degeneration assets presented at the American Academy of Ophthalmology meeting.Eichenbaum noted that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback